BioCentury
ARTICLE | Clinical News

Danegaptide: Phase II data

March 14, 2016 7:00 AM UTC

Top-line data from a double-blind, Danish Phase II trial in about 591 patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI) showe...